Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,741,549
-$4,917,528 QoQ
Shares Held
91,367
+1.9% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#164
of 665 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Treasurer of the State of North Carolina holds $265,264,291 across 24 Biotechnology names. INSM ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,303 | $53,797,349 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,132 | $37,494,707 | |
| 3 | RPRX |
Royalty Pharma plc
|
558,913 | $31,338,251 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
56,779 | $17,092,182 | |
| 5 | INCY |
Incyte Corp
|
144,551 | $16,386,301 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
81,480 | $15,259,574 | |
| 7 | MRNA |
Moderna, Inc.
|
154,987 | $10,853,739 | |
| 8 | INSM |
INSMED Inc
This page
|
91,367 | $9,741,549 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,741,549 | 91,367 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,659,077 | 89,647 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,270,269 | 87,740 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,061,125 | 83,752 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,392,369 | 83,390 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $2,883,800 | 41,770 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,102,500 | 42,500 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||